FDA clears TRIA's acne treatment device for OTC
This article was originally published in The Rose Sheet
TRIA Beauty is planning a spring 2010 launch for its blue light device designed for home treatment of acne, after receiving over-the-counter clearance from FDA, firm announces. The device will debut on TRIABeauty.com and at select retailers. Firm says its blue light technology is 10 times more powerful than other OTC blue light devices, and that it delivers clear skin faster with shorter treatment times. TRIA cites clinical studies demonstrating the technology "cleared breakouts as quickly and effectively as professional blue light treatments." The company's home-use permanent laser hair-removal device received FDA approval in 2007; it retails for $595 (1"The Rose Sheet" Nov. 9. 2009)
You may also be interested in...
TRIA Beauty has upgraded its laser hair-removal device, knocked $200 off the price and launched a multimedia marketing campaign to entice shoppers this holiday season
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.